日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Response to the Letter to the Editor Entitled "Integrating Tissue Proteomics and Urinary Analysis to Capture Dynamic Podocyte Injury"

对题为“整合组织蛋白质组学和尿液分析以捕捉动态足细胞损伤”的读者来信的回应

期刊:Kidney International Reports
影响因子:5.7
doi:10.1016/j.ekir.2026.106474
Fervenza, Fernando C; Vargas-Brochero, Maria J; Debiec, Hanna; Ronco, Pierre; Sethi, Sanjeev
细胞生物学
发表日期：2026
文献求助 收藏

Evaluating Chronicity Scores for Outcomes in Patients With Lupus Nephritis

评估慢性化评分对狼疮性肾炎患者预后的影响

期刊:Kidney International Reports
影响因子:5.7
doi:10.1016/j.ekir.2026.103778
Cuéllar-Gutiérrez, María C; Navarro-Mendoza, Erika; Flores-Gouyonnet, Jaime; Figueroa-Parra, Gabriel; Williamson, Katrina A; Moura, Marta Casal; Fervenza, Fernando C; Hanson, Andrew C; Crowson, Cynthia S; Duarte-García, Alí; Sethi, Sanjeev
肾炎
发表日期：2026
文献求助 收藏

Is Obinutuzumab the Answer to Primary Membranous Nephropathy Resistant to Rituximab?

奥妥珠单抗是治疗利妥昔单抗耐药性原发性膜性肾病的答案吗？

期刊:Kidney International Reports
影响因子:5.7
doi:10.1016/j.ekir.2026.106416
Giri, Kajaree; Glassock, Richard J; Fervenza, Fernando C
发表日期：2026
文献求助 收藏

Antiproteinuric effect of SGLT2 inhibitors in non-diabetic glomerulopathies is dependent on body mass index

SGLT2抑制剂在非糖尿病肾小球疾病中的抗蛋白尿作用取决于体重指数

期刊:Nephrology Dialysis Transplantation
影响因子:5.6
doi:10.1093/ndt/gfaf197
Vargas-Brochero, Maria J; Russo, Ilario; Mazzierli, Tommaso; Cara, Anila; Berti, Gian Marco; Milheiro, Joaquim; Thongprayoon, Charat; Allinovi, Marco; Somma, Chiara; Raglianti, Valentina; D'Arpino, Emanuele; Zand, Ladan; Nuñez-Delgado, Sara; Soler, Maria Jose; Sethi, Sanjeev; Gutiérrez, Eduardo; Praga, Manuel; Caravaca-Fontan, Fernando; Romagnani, Paola; Fervenza, Fernando C
SGLT2
糖尿病
代谢
发表日期：2026
文献求助 收藏

Microscopic hematuria in IgA nephropathy: a biomarker of disease activity

IgA肾病中的镜下血尿：疾病活动性的生物标志物

期刊:Clinical Kidney Journal
影响因子:4.6
doi:10.1093/ckj/sfag003
Floege, Jürgen; Fervenza, Fernando C; Coppo, Rosanna
IgA
发表日期：2026
文献求助 收藏

A case of adrenal insufficiency after initiation of targeted-release budesonide formulation (Nefecon) in a patient with IgA nephropathy

一例IgA肾病患者在使用靶向释放布地奈德制剂（奈非康）后出现肾上腺功能不全的病例报告。

期刊:Clinical Kidney Journal
影响因子:4.6
doi:10.1093/ckj/sfag037
Laxamana, Trisha D; Fervenza, Fernando C; Glassock, Richard J; Zand, Ladan
IgA
免疫/内分泌
发表日期：2026
文献求助 收藏

Bactrim Efficacy in Preventing Infections in Glomerular Diseases Receiving Rituximab

利妥昔单抗治疗肾小球疾病患者中，复方新诺明预防感染的疗效

期刊:Kidney Medicine
影响因子:3.4
doi:10.1016/j.xkme.2026.101275
Miao, Jing; Vaughan, Lisa E; Krisanapan, Pajaree; Vargas-Brochero, Maria J; Thongprayoon, Charat; Mekraksakit, Poemlarp; Fervenza, Fernando; Zand, Ladan
炎症/感染
发表日期：2026
文献求助 收藏

The Mayo MGRS Prediction Tool calculates the risk of finding monoclonal gammopathy of renal significance in a kidney biopsy in patients with monoclonal gammopathy

Mayo MGRS预测工具用于计算单克隆丙种球蛋白病患者在肾活检中发现肾脏意义的单克隆丙种球蛋白病的风险。

期刊:Kidney International
影响因子:12.6
doi:10.1016/j.kint.2025.04.018
Klomjit, Nattawat; Evans, Michael D; Vargas, Maria; Marka, Nicholas; Fervenza, Fernando C; Sethi, Sanjeev; Zand, Ladan
发表日期：2025
文献求助 收藏

Predicting Remission in Antiphospholipase A2 Receptor Antibody-Associated Membranous Nephropathy: A Secondary Analysis of the GEMRITUX, MENTOR, and STARMEN Trials

预测抗磷脂酶A2受体抗体相关性膜性肾病缓解：GEMRITUX、MENTOR和STARMEN试验的二次分析

期刊:Clinical Journal of the American Society of Nephrology
影响因子:7.1
doi:10.2215/CJN.0000000694
Barbour, Sean J; Ronco, Pierre; Praga, Manuel; Fervenza, Fernando C; Induruwage, Dilshani; Zhu, Bingyue; Debiec, Hanna; Fernández-Juárez, Gema; Caravaca-Fontán, Fernando; Cattran, Daniel C
信号转导
STAR
发表日期：2025
文献求助 收藏

Targeting the Optimal Antibody Strategy for a Noninvasive Diagnosis of Phospholipase A2 Receptor-Associated Membranous Nephropathy: Is Serology Alone Sufficient?

针对磷脂酶 A2 受体相关膜性肾病无创诊断的最佳抗体策略：仅血清学检测是否足够？

期刊:Clinical Journal of the American Society of Nephrology
影响因子:7.1
doi:10.2215/CJN.0000000710
Bobart, Shane A; Fervenza, Fernando C
信号转导
发表日期：2025
文献求助 收藏